Coronary microvascular function in patients with Cushing's syndrome

Endocrine

Volumn 43, Issue 1, 2013, Pages 206-213

  Fallo, Francesco ^a   Famoso, Giulia ^a   Capizzi, Dario ^a   Sonino, Nicoletta ^a   Dassie, Francesca ^a   Maffei, Pietro ^a   Martini, Chiara ^a   Paoletta, Agostino ^b   Iliceto, Sabino ^a   Tona, Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Azienda Unità Sanitaria Locale Socio Sanitaria 6 Euganea   (Italy)

Author keywords

Coronary flow reserve; Cushing's syndrome; Heart

Indexed keywords

ADENOSINE; HYDROCORTISONE;

ADRENAL CORTEX ADENOMA; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY FLOW RESERVE; CUSHING SYNDROME; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84872338005     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9764-2     Document Type: Article

References (42)

1. M. Boscaro, L. Barzon, F. Fallo, N. Sonino, Cushing's syndrome. Lancet 357, 783-791 (2001)
2. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593-5602 (2003)
3. T. Mancini, B. Kola, F. Mantero, M. Boscaro, G. Arnaldi, High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin. Endocrinol. (Oxf) 61, 768-777 (2004)
4. R. Pivonello, A. Faggiano, G. Lombardi, A. Colao, The metabolic syndrome and the cardiovascular risk in Cushing's syndrome. Endocrinol. Metab. Clin. North Am. 34, 327-339 (2005)
5. F. Fallo, N. Sonino, Should we evaluate for cardiovascular disease in patients with Cushing's syndrome? Clin. Endocrinol. (Oxf) 71, 768-771 (2009)
6. R.N. Clayton, D. Raskauskiene, R.C. Reulen, P.W. Jones, Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. 96, 632-642 (2011)
7. M.L. Muiesan, M. Lupia, M. Salvetti, C. Grigoletto, N. Sonino, M. Boscaro, E.A. Rosei, F. Mantero, F. Fallo, Left ventricular structural and functional characteristics in Cushing's syndrome. J. Am. Coll. Cardiol. 41, 2275-2279 (2003)
8. A.M. Pereira, V. Delgado, J.A. Romijn, J.W. Smit, J.J. Bax, R.A. Feelders, Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome. Eur. J. Endocrinol. 162, 331-340 (2010)
9. K.H. Yiu, N.A. Marsan, V. Delgado, N.R. Biermasz, E.R. Holman, J.W. Smit, R.A. Feelders, J.J. Bax, A.M. Pereira, Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome. Eur. J. Endocrinol. 166, 27-34 (2012)
10. P.M. Toja, G. Branzi, F. Ciambellotti, P. Radaelli, M. De Martin, L.M. Lonati, M. Scacchi, G. Parati, F. Cavagnini, F.P. Giraldi, Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure. Clin. Endocrinol. (Oxf) 76, 332-338 (2012)
11. K.L. Gould, K. Lipscom, G.W. Hamilton, Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am. J. Cardiol. 33, 87-94 (1974)
12. C. Caiati, C. Montaldo, N. Zedda, R. Montisci, M. Ruscazio, G. Lai, M. Cadeddu, L. Meloni, S. Iliceto, Validation of a new noninvasive method (contrast enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve. Comparison with intracoronary Doppler flow wire. J. Am. Coll. Cardiol. 34, 1193-2000 (1999)
13. P.G. Camici, F. Crea, Coronary microvascular dysfunction. N. Eng. J. Med. 356, 830-840 (2007)
14. T. Kiviniemi, Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography. Clin. Physiol. Funct. Imag. 28, 145-155 (2008)
15. D. Rizzoni, C. Palombo, E. Porteri, M.L. Muiesan, M. Kozà kovà, G. La Canna, M. Nardi, D. Guelfi, M. Salvetti, C. Morizzo, F. Vittone, E.A. Rosei, Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J. Hypertens. 21, 625-631 (2003)
16. M. Ragosta, H. Samady, R.B. Isaacs, L.W. Gimple, I.J. Sarembock, E.R. Powers, Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am. Heart J. 147, 1017-1023 (2004)
17. M. Galderisi, G. de Simone, S. Cicala, M. Parisi, A. D'Errico, P. Innelli, M. de Divitiis, S. Mondillo, O. de Divitiis, Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease. Am. J. Hypertens. 20, 177-183 (2007)
18. F. Fallo, A. Paoletta, F. Tona, M. Boscaro, N. Sonino, Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome. J. Int. Med. 234, 595-598 (1993)
19. P. Della Mea, M. Lupia, V. Bandolin, S. Guzzon, N. Sonino, R. Vettor, F. Fallo, Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am. J. Hypertens. 18, 30-35 (2005)
20. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J. Shanewise, S. Solomon, K.T. Spencer, M. St John Sutton, W. Stewart, American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur. J. Echocardiogr. 7, 79-108 (2006)
21. G. de Simone, S.R. Daniels, R.B. Devereux, R.A. Meyer, M.J. Roman, O. de Divitiis, M.H. Alderman, Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and of the impact of overweight. J. Am. Coll. Cardiol. 19, 1550-1558 (1992)
22. F. Tona, A.L. Caforio, R. Montisci, A. Gambino, A. Angelini, M. Ruscazio, G. Toscano, G. Feltrin, A. Ramondo, G. Gerosa, S. Iliceto, Coronary flow velocity pattern and coronary flow reserve by contrast-enhanced transthoracic echocardiography predict long-term outcome in heart transplantation. Circulation 114(1 Suppl), I49-I55 (2006)
23. R. Rubinshtein, E.H. Yang, C.S. Rihal, A. Prasad, R.J. Lennon, P.J. Best, L.O. Lerman, A. Lerman, Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur. Heart J. 31, 936-942 (2010)
24. W.G. Austen, J.E. Edwards, R.L. Frye, G.G. Gensini, V.L. Gott, L.S. Griffith, D.C. McGoon, M.L. Murphy, B.B. Roe, A reporting system on patients evaluated for coronary artery disease: report of the ad hoc committee for grading of coronary artery disease, Council on Cardiovascular Surgery, Dallas, TX: American Heart Association. Circulation 51, 5-40 (1975)
25. F. Rigo, L. Cortigiani, E. Pasanisi, M. Richieri, V. Cutaia, M. Celestre, A. Raviele, E. Picano, The additional prognostic value of coronary flow reserve on left anterior descending artery in patients with negative stress echo by wall motion criteria. A transthoracic vasodilator stress echocardiography study. Am. Heart J. 151, 124-130 (2006)
26. G.D. Smith, Y. Ben-Shlomo, A. Beswick, J. Yarnell, S. Lightman, P. Elwood, Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112, 332-340 (2005)
27. J. Nijm, L. Jonasson, Inflammation and cortisol response in coronary artery disease. Ann. Med. 41, 224-233 (2009)
28. R. Fraser, M.C. Ingram, N.H. Andre, C. Morrison, E. Davies, J.M.C. Connell, Cortisol effects on body mass, blood pressure and cholesterol in the general population. Hypertension 33, 1364-1368 (1999)
29. B.R. Walker, S. Soderberg, B. Lindhal, T. Ollsson, Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J. Intern. Med. 247, 198-204 (2000)
30. Y. Imai, K. Abe, S. Sasaki, N. Minami, M. Nihei, M. Munakata, O. Murakami, K. Matsue, H. Sekino, Y. Miura, K. Yoshinaga, Altered circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 12, 11-19 (1988)
31. F. Fallo, P. Maffei, A. Dalla Pozza, M. Carli, P. Della Mea, M. Lupia, F. Rabbia, N. Sonino, Cardiovascular autonomic function in Cushing's syndrome. J. Endocrinol. Invest. 32, 41-44 (2009)
32. T. Ohkubo, A. Hozawa, J. Yamaguchi, M. Kikuya, K. Ohmori, M. Michimata, M. Matsubara, J. Hashimoto, H. Hoshi, T. Araki, I. Tsuji, H. Satoh, S. Hisamichi, Y. Imai, Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183-2189 (2002)
33. S. Schäfer, M. Kelm, S. Mingers, B.E. Strauer, Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J. Hypertens. 20, 1431-1437 (2002)
34. L. Kornel, W.A. Nelson, B. Manisundaram, R. Chigurupati, T. Hayashi, Mechanism of the effects of glucocorticoids and mineralocorticoids on vascular smooth muscle contractility. Steroids 58, 580-587 (1993)
35. H. Inoue, K. Humesono, T. Nishimori, Y. Hirata, T. Tanabe, Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem. Biophys. Res. Commun. 254, 292-298 (1999)
36. I. Akaza, T. Yoshimoto, K. Tsuchiya, Y. Hirata, Endothelial dysfunction associated with hypercortisolism is reversible in Cushing's syndrome. Endocr. J. 57, 245-552 (2010)
37. T.J. Anderson, A. Uehata, M.D. Gerhard, I.T. Meredith, S. Knab, D. Delagrange, E.H. Lieberman, P. Ganz, M.A. Creager, A.C. Yeung, A.P. Selwyn, Close relation of endothelial function in the human coronary and peripheral circulations. J. Am. Coll. Cardiol. 26, 1235-1241 (1995)
38. J.A. Whitworth, G.J. Mangos, J.J. Kelly, Cushing, cortisol, and cardiovascular disease. Hypertension 36, 912-916 (2000)
39. M. Rosenstock, S. Katz, A. Danon, Glucocorticoids regulate both phorbol ester and calcium ionophore-induced endothelial prostacyclin synthesis. Prostag. Leukotr. Ess. Fatty Acids 56, 1-8 (1997)
40. S.S. Jun, Z. Chen, M.C. Pace, P.W. Shaul, Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circ. Res. 84, 193-200 (1999)
41. K.M. Rogers, C.A. Bonar, J.L. Estrella, S. Yang, Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am. J. Physiol. Heart Circ. Physiol. 283, H1922-H1928 (2002)
42. S.L. Ong, J.A. Whitworth, How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Endocrinol. Metab. Clin. North Am. 40, 393-407 (2011)